INS and endothelial dysfunction: NO metabolites, NO synthase inhibitors, and N-acetyl-β-glucosaminidase (NAGase) are biomarkers capable of measuring endothelial dysfunction and oxidative stress in the early stages of impaired response to insulin [101].